×
ADVERTISEMENT

340B

Legislation, Manufacturer Campaigns Buffet 340B Program

At the 2025 340B Winter Coalition Conference, discussions, policy updates and industry trends provided valuable ...

AUGUST 20, 2025

Evolving 340B Program Requires Nimble Administrators

Third-party administrators have long been one of the most essential partners for hospitals and health systems ...

MAY 31, 2025

New Administration’s Impact on 340B Program: TBD

How could the second Trump administration affect the federal 340B Drug Pricing Program? It’s yet to be ...

APRIL 2, 2025

Take a Closer Look at 340B Spend Data

Routine audits of 340B billing practices could yield new revenues for health systems that rely on funding from the ...

JANUARY 29, 2025

Second Trump Administration Impact on 340B Program to Be Determined

How could the second Trump administration affect the federal 340B Drug Pricing Program? It’s yet to be ...

NOVEMBER 21, 2024

340B Participation May Hamper Biosimilars Uptake

Are hospitals participating in the federal 340B Drug Pricing Program less motivated to prescribe biosimilars over ...

AUGUST 14, 2024

HHS Finalizes Rule on 340B Administrative Dispute Resolution Process

The Department of Health and Human Services is refreshing its dispute resolution process in the federal 340B drug ...

APRIL 19, 2024

Adding Fertility Drugs To Specialty Pharmacy Saves Nearly $1 M/Year

Patients in Oklahoma receive specialty fertility medications far more quickly and at significantly less cost than ...

APRIL 12, 2024

Biogen and Novartis Withdraw 340B Contract Pharmacy Restrictions in Arkansas

Less than a week after a federal appellate court upheld an Arkansas law prohibiting drug companies from imposing ...

MARCH 20, 2024

340Bs, Injectables Caught Up in Drug Shortages Debate

Representatives of 340B covered entities are calling for modifications to the discussion draft of a bill in the ...

DECEMBER 2, 2023

How Good Is the Tech Provided by Your 340B Administrator?

The Health Resources and Services Administration audits about 200 participants in the federal 340B Drug Pricing ...

SEPTEMBER 12, 2023

CMS Proposes One-Time $9 Billion Restitution To Fix Years of 340B Underpayments

One year after a 2022 Supreme Court decision that the CMS did not have the authority to lower reimbursement rates ...

JULY 14, 2023

Load more